미림진, 2022년도 제3차 국가신약개발사업 연구과제 선정 / MirimGENE, Selected as a research project for the 3rd KDDF in 2022
POSTED ON September 13, 2022
The
Korea Drug Development Fund announced the selected research projects for the
3rd National New Drug Development Program in 2022.
At this time, the selected projects consist of two areas : “Research on building a new drug R&D ecosystem" and “Clinical development of new drugs," for a total of 26 projects.
New drugs developed by MirimGENE and other companies have been selected as government-supported research projects.
At this time, the selected projects consist of two areas : “Research on building a new drug R&D ecosystem" and “Clinical development of new drugs," for a total of 26 projects.
New drugs developed by MirimGENE and other companies have been selected as government-supported research projects.
Source : KDDF